Skip to content

Basic and clinical research on the etiology and prognosis of liver cancer

Basic and clinical research on the etiology and prognosis of liver cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200066839
Enrollment
Unknown
Registered
2022-12-19
Start date
2022-03-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver cancer

Interventions

HCC:NA
ICC:NA
HCC-ICC:NA

Sponsors

East Branch of Shandong Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) The patient's specific condition is good, there are no obvious organic lesions of the heart, lungs, kidneys and other important organs, the liver function is normal or only mildly damaged, and there is a certain degree of tolerance to surgery. (2) There is no extensive extrahepatic metastatic tumor foci, and the remaining liver can be compensated after surgical resection. (3) Pathological diagnosis of hepatocellular carcinoma, intrahepatic cholangiocarcinoma or mixed liver cancer

Exclusion criteria

Exclusion criteria: (1) Accompanied by other malignant tumors. (2) Patients with severe heart, kidney, lung, kidney disease or circulatory system disorders. (3) Those with mental illness, cognitive dysfunction or poor treatment compliance. (4) Those who are transferred to hospital during the perioperative period or stop surgery midway and switch to conservative treatment.

Design outcomes

Primary

MeasureTime frame
Blood test indicators;

Secondary

MeasureTime frame
single-cell RNA sequencing;

Countries

China

Contacts

Public ContactNi Qingqiang

East Branch of Shandong Provincial Hospital

niqingqiang@sdfmu.edu.cn+86 531 68773231

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026